Question 1

Am I eligible for this trial based on my current treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Molecular Endotypes of Chronic Idiopathic Urticaria clinical trial (NCT04774315). Contact the study team or your healthcare provider for specific answers.

Question 2

How does omalizumab work for Chronic Idiopathic Urticaria?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Molecular Endotypes of Chronic Idiopathic Urticaria clinical trial (NCT04774315). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of omalizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Molecular Endotypes of Chronic Idiopathic Urticaria clinical trial (NCT04774315). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Molecular Endotypes of Chronic Idiopathic Urticaria clinical trial (NCT04774315). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I don't respond to the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Molecular Endotypes of Chronic Idiopathic Urticaria clinical trial (NCT04774315). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs or travel requirements associated with participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Molecular Endotypes of Chronic Idiopathic Urticaria clinical trial (NCT04774315). Contact the study team or your healthcare provider for specific answers.

What this study is about